Your browser doesn't support javascript.
loading
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
Liu, Pengyu; Wang, Wenxuan; Wang, Fei; Fan, Jiaqi; Guo, Jinan; Wu, Tao; Lu, Dongliang; Zhou, Qingchun; Liu, Zhuohao; Wang, Yuliang; Shang, Zhiqun; Chan, Franky Leung; Yang, Wei; Li, Xin; Zhao, Shan-Chao; Zheng, Qingyou; Wang, Fei; Wu, Dinglan.
Afiliación
  • Liu P; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Wang W; Department of Medical Genetics and Developmental Biology, School of Medicine, Southeast University, Nanjing, China.
  • Wang F; Department of Urology, Guangdong Hospital of Traditional Chinese Medicine, Zhuhai, Guangdong Province, 519015, China.
  • Fan J; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Guo J; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Wu T; Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong Province, China.
  • Lu D; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Zhou Q; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Liu Z; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Wang Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Shang Z; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Chan FL; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Yang W; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, SAR, China.
  • Li X; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Zhao SC; Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.
  • Zheng Q; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
  • Wang F; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510500, China. lulululu@smu.edu.cn.
  • Wu D; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. lulululu@smu.edu.cn.
J Transl Med ; 21(1): 40, 2023 01 21.
Article en En | MEDLINE | ID: mdl-36681849
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Exosomas / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China